Cargando…

Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy

Aiming to promote cancer cell apoptosis is a mainstream strategy of cancer therapy. The second mitochondria-derived activator of caspase (SMAC)/direct inhibitor of apoptosis protein (IAP)-binding protein with low pI (DIABLO) protein is an essential and endogenous antagonist of inhibitor of apoptosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xiao-Yun, Wang, Xiu-Yun, Wei, Qi-Yao, Xu, Yan-Ming, Lau, Andy T. Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226512/ https://www.ncbi.nlm.nih.gov/pubmed/32325691 http://dx.doi.org/10.3390/cells9041012

Ejemplares similares

Role of Smac/DIABLO in cancer progression
por: Martinez-Ruiz, Gustavo, et al.
Publicado: (2008)

Dual-targeting peptides@PMO, a mimetic to the pro-apoptotic protein Smac/DIABLO for selective activation of apoptosis in cancer cells
por: Di Giorgio, Eros, et al.
Publicado: (2023)

Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1
por: Xie, Wei, et al.
Publicado: (2006)

CD4+ T cell-mimicking nanoparticles encapsulating DIABLO/SMAC mimetics broadly neutralize HIV-1 and selectively kill HIV-1-infected cells
por: Campbell, Grant R., et al.
Publicado: (2021)

SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis
por: Pandey, Swaroop Kumar, et al.
Publicado: (2021)

Effects of Fluid Shear Stress on Expression of Smac/DIABLO in Human Umbilical Vein Endothelial Cells()
por: Zhang, Feng, et al.
Publicado: (2013)

Future Therapeutic Directions for Smac-Mimetics
por: Morrish, Emma, et al.
Publicado: (2020)

The role of SMAC mimetics in regulation of tumor cell death and immunity
por: Emeagi, Perpetua U., et al.
Publicado: (2012)

Real-time single cell analysis of Smac/DIABLO release during apoptosis
por: Rehm, Markus, et al.
Publicado: (2003)

High Smac/DIABLO expression is associated with early local recurrence of cervical cancer
por: Arellano-Llamas, Abril, et al.
Publicado: (2006)

New light on Smac mimetics and breast cancer
por: Cornmark, L, et al.
Publicado: (2016)

Hyperosmotic stress enhances cytotoxicity of SMAC mimetics
por: Bittner, Sebastian, et al.
Publicado: (2017)

SMAC Mimetics as Therapeutic Agents in HIV Infection
por: Molyer, Bengisu, et al.
Publicado: (2021)

Smac/DIABLO expression in human gastrointestinal carcinoma: Association with clinicopathological parameters and survivin expression
por: SHINTANI, MICHIKO, et al.
Publicado: (2014)

Smac mimetics and innate immune stimuli synergize to promote tumor death
por: Beug, Shawn T., et al.
Publicado: (2014)

Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells: mechanistic studies of Smac mimetic
por: Balakrishnan, Kumudha, et al.
Publicado: (2016)

Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas
por: Yan, Y, et al.
Publicado: (2004)

Redox regulation of Smac mimetic-induced cell death
por: Fulda, Simone
Publicado: (2015)

Smac-mimetics reduce numbers and viability of human osteoclasts
por: Moen, Ingrid Nyhus, et al.
Publicado: (2021)

Opposite regulation of XIAP and Smac/DIABLO in the rat endometrium in response to 17β-estradiol at estrus
por: Leblanc, Valerie, et al.
Publicado: (2003)

Osmostress-Induced Apoptosis in Xenopus Oocytes: Role of Stress Protein Kinases, Calpains and Smac/DIABLO
por: Messaoud, Nabil Ben, et al.
Publicado: (2015)

MiR-24-BIM-Smac/DIABLO axis controls the sensitivity to doxorubicin treatment in osteosarcoma
por: Sun, Yangbai, et al.
Publicado: (2016)

Modulation of Respiration and Mitochondrial Dynamics by SMAC-Mimetics for Combination Therapy in Chemoresistant Cancer
por: Hagenbuchner, Judith, et al.
Publicado: (2019)

Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma
por: Dobrzycka, Bozena, et al.
Publicado: (2015)

Regulation of cancer stem-like cell differentiation by Smac mimetics
por: Fulda, Simone
Publicado: (2014)

Targeting triple-negative breast cancers with the Smac-mimetic birinapant
por: Lalaoui, Najoua, et al.
Publicado: (2020)

Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells
por: Fandy, Tamer E, et al.
Publicado: (2008)

Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancer
por: MIZUTANI, YOICHI, et al.
Publicado: (2012)

Integrin-Targeting Dye-Doped PEG-Shell/Silica-Core Nanoparticles Mimicking the Proapoptotic Smac/DIABLO Protein
por: De Marco, Rossella, et al.
Publicado: (2020)

The role of NF-κB and Smac/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patients
por: Pluta, Agnieszka, et al.
Publicado: (2019)

SMG1 and NIK regulate apoptosis induced by Smac mimetic compounds
por: Cheung, H H, et al.
Publicado: (2011)

Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer
por: Awasthi, Niranjan, et al.
Publicado: (2011)

The TwistDock workflow for evaluation of bivalent Smac mimetics targeting XIAP
por: Huang, Qingsheng, et al.
Publicado: (2019)

Quaternary Benzophenanthridine Alkaloids Act as Smac Mimetics and Overcome Resistance to Apoptosis
por: Kulíšková, Petra, et al.
Publicado: (2023)

Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
por: Hermida-Prado, Francisco, et al.
Publicado: (2023)

The SMAC mimetic LCL-161 selectively targets JAK2(V617F) mutant cells
por: Craver, Brianna M., et al.
Publicado: (2020)

The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein
por: Mariniello, Raffaela Mariarosaria, et al.
Publicado: (2020)

Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression
por: Pandey, Swaroop Kumar, et al.
Publicado: (2022)

Development of a FACS-based Smac/DIABLO release assay to monitor individual drug responses and to pave the way towards patient-tailored therapies
por: Arora, Jigyasa, et al.
Publicado: (2015)

Smac mimetics combined with innate immune stimuli create the perfect cytokine storm to kill tumor cells
por: Beug, Shawn T, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vt0eldbetuarsfp7q4k39qkqdf